´ç´¢º´¼º ¸Á¸·Áõ ½ÃÀå º¸°í¼­ : À¯Çüº°, Ä¡·á À¯Çüº°, ÃÖÁ¾ »ç¿ëÀÚº°, Áö¿ªº°(2025-2033³â)
Diabetic Retinopathy Market Report by Type, Treatment Type, End-User (Hospitals and Pharmacies, Eye Clinics, Ambulatory Surgical Centres, and Others), and Region 2025-2033
»óǰÄÚµå : 1792391
¸®¼­Ä¡»ç : IMARC Group
¹ßÇàÀÏ : 2025³â 08¿ù
ÆäÀÌÁö Á¤º¸ : ¿µ¹® 138 Pages
 ¶óÀ̼±½º & °¡°Ý (ºÎ°¡¼¼ º°µµ)
US $ 2,999 £Ü 4,221,000
PDF & Excel (Single User License) help
PDF & Excel º¸°í¼­¸¦ 1¸í¸¸ ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. Àμ⠺Ұ¡´ÉÇϸç, ÅØ½ºÆ® µîÀÇ Copy&Pasteµµ ºÒ°¡´ÉÇÕ´Ï´Ù.
US $ 3,999 £Ü 5,628,000
PDF & Excel (5 User License) help
PDF & Excel º¸°í¼­¸¦ µ¿ÀÏ ±â¾÷ÀÇ 5¸í±îÁö ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. ÅØ½ºÆ® µîÀÇ Copy&Paste°¡ ºÒ°¡´ÉÇÕ´Ï´Ù. Àμâ´Â 5ºÎ±îÁö °¡´ÉÇϸç, Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â PDF ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.
US $ 4,999 £Ü 7,036,000
PDF & Excel (Corporate License) help
PDF & Excel º¸°í¼­¸¦ µ¿ÀÏ ±â¾÷ÀÇ 5¸í±îÁö ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. ÅØ½ºÆ® µîÀÇ Copy&Paste°¡ ºÒ°¡´ÉÇÕ´Ï´Ù. Àμâ´Â 5ºÎ±îÁö °¡´ÉÇϸç, Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â PDF ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.


¤± Add-on °¡´É: °í°´ÀÇ ¿äû¿¡ µû¶ó ÀÏÁ¤ÇÑ ¹üÀ§ ³»¿¡¼­ CustomizationÀÌ °¡´ÉÇÕ´Ï´Ù. ÀÚ¼¼ÇÑ »çÇ×Àº ¹®ÀÇÇØ Áֽñ⠹ٶø´Ï´Ù.

Çѱ۸ñÂ÷

¼¼°è ´ç´¢º´¼º ¸Á¸·Áõ ½ÃÀå ±Ô¸ð´Â 2024³â 85¾ï ´Þ·¯¿¡ ´ÞÇß½À´Ï´Ù. ÇâÈÄ IMARC ±×·ìÀº 2033³â¿¡´Â 132¾ï ´Þ·¯¿¡ À̸£°í, 2025³âºÎÅÍ 2033³â±îÁö 5%ÀÇ ¿¬Æò±Õ º¹ÇÕ ¼ºÀå·ü(CAGR)·Î ¼ºÀåÇÒ °ÍÀ¸·Î ¿¹ÃøÇß½À´Ï´Ù. ´ç´¢º´ À¯º´·üÀÇ ±ÞÁõ, È¿°úÀûÀÎ Ä¡·á¿¡ ´ëÇÑ ¼ö¿ä Áõ°¡, ´ç´¢º´¼º ¸Á¸·ÁõÀÇ Á¶±â Áø´Ü°ú Ä¡·á¿¡ ´ëÇÑ ÀÇ½Ä Áõ°¡°¡ ½ÃÀåÀ» °ßÀÎÇÏ´Â ÁÖ¿ä ¿äÀÎ Áß ÇϳªÀÔ´Ï´Ù.

´ç´¢º´¼º ¸Á¸·Áõ(DR)Àº ºûÀ» °¨ÁöÇÏ°í ³ú¿¡ ½ÅÈ£¸¦ º¸³»´Â ´«ÀÇ ÀϺÎÀÎ ¸Á¸·¿¡ ¿µÇâÀ» ¹ÌÄ¡´Â ´ç´¢º´ÀÇ ÀϹÝÀûÀÎ ÇÕº´ÁõÀÔ´Ï´Ù. °íÇ÷´çÀÌ ¸Á¸·ÀÇ ¾ãÀº Ç÷°ü¿¡ ¼Õ»óÀ» ÁÖ°í Ç÷°üÀÌ »õ°Å³ª ¸·Çô¼­ ¹ßº´ÇÕ´Ï´Ù. ¹æÄ¡ÇÏ¸é ½Ã·Â ÀúÇϳª ½Ç¸íÀ¸·Î À̾îÁý´Ï´Ù. ´ç´¢º´¸Á¸·ÁõÀ¸·Î´Â Å©°Ô ³ª´©¾î ºñÁõ½Ä¼º ´ç´¢º´¸Á¸·Áõ°ú Áõ½Ä¼º ´ç´¢º´¸Á¸·ÁõÀÇ 2À¯Çü°¡ ÀÖ½À´Ï´Ù. ÀÌ Áø´Ü¿¡´Â Ç÷ç¿À·¹¼¼ÀÎ Ç÷°ü Á¶¿µ¼ú ¹× ±¤ÇÐ ´ÜÃþ ÃÔ¿µ¼ú°ú °°Àº °Ë»ç¸¦ Æ÷ÇÔÇÑ Á¾ÇÕÀûÀÎ ¾È°ú °Ë»ç°¡ ÇÊ¿äÇÕ´Ï´Ù. ÀÌ·¯ÇÑ °Ë»ç´Â DRÀÇ Á¸Àç¿Í ÁßÁõµµ¸¦ È®ÀÎÇϰí Á¶±â °³ÀÔ°ú Ä¡·á¸¦ °¡´ÉÇÏ°Ô ÇÕ´Ï´Ù. ÇöÀç DR¿¡´Â ½ºÅ×·ÎÀÌµå ¾È±¸ ÁÖ»ç, ·¹ÀÌÀú Ä¡·á, À¯¸®Ã¼ ¼ö¼ú µîÀÇ Ä¡·á¹ýÀÌ ÀÖ½À´Ï´Ù. ¾È±¸ ½ºÅ×·ÎÀ̵å ÁÖ»ç´Â ¾È±¸ÀÇ ¿°Áõ°ú º×±â¸¦ ¾ïÁ¦ÇÏ´Â µ¥ µµ¿òÀÌ µÇ¸ç ·¹ÀÌÀú Ä¡·á´Â ´©Ãâ µÈ Ç÷°üÀ» ¸·°í ¸Á¸·ÀÇ Ãß°¡ ¼Õ»óÀ» ¹æÁöÇÏ´Â µ¥ »ç¿ëµË´Ï´Ù. ½É°¢ÇÑ °æ¿ì¿¡´Â ¾È±¸¿¡¼­ Ç÷¾×°ú ÈäÅÍ Á¶Á÷À» Á¦°ÅÇϱâ À§ÇØ À¯¸®Ã¼ ¼ö¼úÀÌ ÇÊ¿äÇÒ ¼ö ÀÖ½À´Ï´Ù.

´ç´¢º´¼º ¸Á¸·Áõ ½ÃÀå µ¿Çâ :

¼¼°èÀÇ ´ç´¢º´¼º ¸Á¸·Áõ ½ÃÀåÀº ÁÖ·Î ´ç´¢º´ÀÇ À¯º´·ü Áõ°¡¿Í ³ë³â Àα¸ Áõ°¡·Î Å« ¼ºÀåÀ» ÀÌ·ç°í ÀÖ½À´Ï´Ù. ÀÌ¿¡ µû¶ó ÁÖ¿ä ±â¾÷Àº ´ç´¢º´¼º ¸Á¸·ÁõÀÇ »õ·Î¿î Ä¡·á ¼Ö·ç¼Ç °³¹ß¿¡ Àû±ØÀûÀ¸·Î ³ë·ÂÇϰí ÀÖÀ¸¸ç ½ÃÀå ¼ºÀåÀ» °¡¼ÓÇϰí ÀÖ½À´Ï´Ù. À̿ʹ º°µµ·Î, Ç×VEGF¾àÀ̳ª ¼­¹æÇü ÀÓÇöõÆ® µîÀÇ ½Å¾àÀ̳ª Ä¡·á¹ýÀÇ °³¹ßµµ ½ÃÀå ¼ºÀå¿¡ Å©°Ô °øÇåÇϰí ÀÖ½À´Ï´Ù. °Ô´Ù°¡ ´ç´¢º´¸Á¸·ÁõÀÇ Áø´ÜÀ̳ª Ä¡·á¿¡ À־ÀÇ ¿ø°ÝÀǷᳪ ÀΰøÁö´É(AI)ÀÇ Ã¤ÅÃÀÌ È®´ëµÇ°í ÀÖ´Â °Íµµ ½ÃÀåÀÇ ¼ºÀåÀ» µÞ¹ÞħÇϰí ÀÖ½À´Ï´Ù. ´ç´¢º´¼º ¸Á¸·Áõ°ú ±× ÀáÀçÀûÀÎ ¿µÇâ¿¡ ´ëÇÑ ÀÎ½Ä Áõ°¡·Î È¿°úÀûÀÎ Ä¡·á¿¡ ´ëÇÑ ¼ö¿ä Áõ°¡´Â ¶Ç ´Ù¸¥ ¼ºÀå ÃËÁø¿äÀÎÀ¸·Î ÀÛ¿ëÇϰí ÀÖ½À´Ï´Ù. ¶ÇÇÑ, ´ç´¢º´¼º ¸Á¸·ÁõÀÇ Á¶±â Áø´Ü°ú Ä¡·á¿¡ ´ëÇÑ ÀÇ½Ä Áõ°¡¿Í ¾È°ú ±â¼úÀÇ Áøº¸°¡ ½ÃÀåÀÇ ¼ºÀåÀ» °¡¼ÓÇϰí ÀÖ½À´Ï´Ù. ±âŸ ¿äÀÎÀ¸·Î´Â ÇコÄɾî ÁöÃâ Áõ°¡, ¾È°ú ÀÇ·á ¼­ºñ½º Çâ»óÀ» À§ÇÑ ´Ù¾çÇÑ Á¤ºÎ ÀÌ´Ï¼ÅÆ¼ºêÀÇ ½Ç½Ã, À¯¸®ÇÑ »óȯ Á¤Ã¥ÀÇ ÀÌ¿ë °¡´É¼º µîÀÌ ½ÃÀå ¼ºÀåÀ» °¡¼ÓÇϰí ÀÖ½À´Ï´Ù.

ÀÌ º¸°í¼­¿¡¼­ ´Ù·ç´Â ÁÖ¿ä Áú¹®

¸ñÂ÷

Á¦1Àå ¼­¹®

Á¦2Àå Á¶»ç ¹üÀ§¿Í Á¶»ç ¹æ¹ý

Á¦3Àå ÁÖ¿ä ¿ä¾à

Á¦4Àå ¼Ò°³

Á¦5Àå ¼¼°èÀÇ ´ç´¢º´¼º ¸Á¸·Áõ ½ÃÀå

Á¦6Àå ½ÃÀå ºÐ¼® : À¯Çüº°

Á¦7Àå ½ÃÀå ³»¿ª : Ä¡·á À¯Çüº°

Á¦8Àå ½ÃÀå ºÐ¼® : ÃÖÁ¾»ç¿ëÀÚº°

Á¦9Àå ½ÃÀå ºÐ¼® : Áö¿ªº°

Á¦10Àå SWOT ºÐ¼®

Á¦11Àå ¹ë·ùüÀÎ ºÐ¼®

Á¦12Àå Porter's Five Forces ºÐ¼®

Á¦13Àå °æÀï ±¸µµ

SHW
¿µ¹® ¸ñÂ÷

¿µ¹®¸ñÂ÷

The global diabetic retinopathy market size reached USD 8.5 Billion in 2024. Looking forward, IMARC Group expects the market to reach USD 13.2 Billion by 2033, exhibiting a growth rate (CAGR) of 5% during 2025-2033. The surging prevalence of diabetes, rising demand for effective treatments, and growing awareness regarding early diagnosis and treatment of diabetic retinopathy represent some of the key factors driving the market.

Diabetic retinopathy (DR) is a common complication of diabetes that affects the retina, the part of the eye that senses light and sends signals to the brain. It occurs when high blood sugar levels damage the small blood vessels in the retina, causing them to leak or become blocked. This can lead to vision loss or blindness if left untreated. There are two main types of diabetic retinopathy, namely non-proliferative diabetic retinopathy and proliferative diabetic retinopathy. Its diagnosis involves a comprehensive eye exam, which may include tests such as fluorescein angiography and optical coherence tomography. These tests can help to identify the presence and severity of DR, allowing for early intervention and treatment. Currently, there are several treatment options available for DR, including the use of intraocular steroid injections, laser treatment, and vitrectomy. Intraocular steroid injections can help to reduce inflammation and swelling in the eye, while laser treatment can be used to seal leaking blood vessels and prevent further damage to the retina. In more severe cases, a vitrectomy may be necessary to remove blood or scar tissue from the eye.

Diabetic Retinopathy Market Trends:

The global diabetic retinopathy market is witnessing significant growth, primarily driven by the rising prevalence of diabetes and the increasing geriatric population. In line with this, key players are actively working to develop new therapeutic solutions for diabetic retinopathy, which is bolstering market growth. Apart from this, the development of new drugs and therapies, such as anti-VEGF agents and sustained-release implants, has also significantly contributed to market growth. Additionally, the escalating adoption of telemedicine and artificial intelligence (AI) in the diagnosis and treatment of diabetic retinopathy is driving the market growth. The rising demand for effective treatments due to the growing awareness of diabetic retinopathy and its potential consequences is acting as another growth-inducing factor. Furthermore, the surging awareness regarding early diagnosis and treatment of diabetic retinopathy, coupled with advancements in ophthalmic technology, are fueling the market growth. Other factors, such as increasing healthcare expenditure, the implementation of various government initiatives to improve eye care services, and the availability of favorable reimbursement policies, are propelling the market growth.

Key Market Segmentation:

Type Insights:

Treatment Type Insights:

End-User Insights:

Regional Insights:

Competitive Landscape:

Key Questions Answered in This Report:

Table of Contents

1 Preface

2 Scope and Methodology

3 Executive Summary

4 Introduction

5 Global Diabetic Retinopathy Market

6 Market Breakup by Type

7 Market Breakup by Treatment Type

8 Market Breakup by End-User

9 Market Breakup by Region

10 SWOT Analysis

11 Value Chain Analysis

12 Porters Five Forces Analysis

13 Competitive Landscape

(ÁÖ)±Û·Î¹úÀÎÆ÷¸ÞÀÌ¼Ç 02-2025-2992 kr-info@giikorea.co.kr
¨Ï Copyright Global Information, Inc. All rights reserved.
PC¹öÀü º¸±â